GRP
BMY.RT

Global Retirement Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Global Retirement Partners’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,069
Closed -$1K – 1952
2020
Q4 		$1K Hold
1,069
– – ﹤0.01% 1719
2020
Q3 		$2K Hold
1,069
– – ﹤0.01% 1533
2020
Q2 		$4K Sell
1,069
-100
-9% -$361 ﹤0.01% 1365
2020
Q1 		$4K Hold
1,169
– – ﹤0.01% 1306
2019
Q4 		$4K Buy
+1,169
New +$3.04K ﹤0.01% 1400

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Global Retirement Partners's BMY.RT Position: Q1 2021 in Review

Global Retirement Partners sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,069 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $4K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Global Retirement Partners reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Global Retirement Partners sold 1,069 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • Global Retirement Partners first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Global Retirement Partners's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $4K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Global Retirement Partners's 13F filing for Q1 2021, filed 14 Apr 2021.